APO RESEARCH · REPORT
Oncolytic Virus
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Product & engineering
Understand the product.
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Selected research
Industry Research
Oncolytic Virus Industry Research Report 2026
Market perspective
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
Report Scope
Read the full market overview
This report quantifies the global Oncolytic Virus market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oncolytic Virus Market by Company
Amgen
Shanghai Sunway Biotech
Oncolytic Virus Segment by Type
Imlygic
Oncorine
Others
Oncolytic Virus Segment by Application
Melanoma
Other Cancers
Oncolytic Virus Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oncolytic Virus by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oncolytic Virus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Imlygic
- Oncorine
- Others
Applications
- Melanoma
- Other Cancers
Companies covered
- Amgen
- Shanghai Sunway Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oncolytic Virus Market Size (2021-2032)
- 2.2.2 Global Oncolytic Virus Sales (2021-2032)
- 2.2.3 Global Oncolytic Virus Market Average Price (2021-2032)
- 2.3 Oncolytic Virus by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Imlygic
- 2.3.3 Oncorine
- 2.3.4 Others
- 2.4 Oncolytic Virus by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Melanoma
- 2.4.3 Other Cancers
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oncolytic Virus Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oncolytic Virus Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Oncolytic Virus Revenue of Manufacturers (2021-2026)
- 3.4 Global Oncolytic Virus Average Price by Manufacturers (2021-2026)
- 3.5 Global Oncolytic Virus Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oncolytic Virus, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oncolytic Virus, Product Type & Application
- 3.8 Global Manufacturers of Oncolytic Virus, Established Date
- 3.9 Global Oncolytic Virus Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amgen
- 4.1.1 Amgen Company Information
- 4.1.2 Amgen Business Overview
- 4.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amgen Oncolytic Virus Product Portfolio
- 4.1.5 Amgen Recent Developments
- 4.2 Shanghai Sunway Biotech
- 4.2.1 Shanghai Sunway Biotech Company Information
- 4.2.2 Shanghai Sunway Biotech Business Overview
- 4.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
- 4.2.5 Shanghai Sunway Biotech Recent Developments
5 Global Oncolytic Virus Market Scenario by Region
- 5.1 Global Oncolytic Virus Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oncolytic Virus Sales by Region: 2021-2032
- 5.2.1 Global Oncolytic Virus Sales by Region: 2021-2026
- 5.2.2 Global Oncolytic Virus Sales by Region: 2027-2032
- 5.3 Global Oncolytic Virus Revenue by Region: 2021-2032
- 5.3.1 Global Oncolytic Virus Revenue by Region: 2021-2026
- 5.3.2 Global Oncolytic Virus Revenue by Region: 2027-2032
- 5.4 North America Oncolytic Virus Market Facts & Figures by Country
- 5.4.1 North America Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oncolytic Virus Sales by Country (2021-2032)
- 5.4.3 North America Oncolytic Virus Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oncolytic Virus Market Facts & Figures by Country
- 5.5.1 Europe Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oncolytic Virus Sales by Country (2021-2032)
- 5.5.3 Europe Oncolytic Virus Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oncolytic Virus Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oncolytic Virus Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oncolytic Virus Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oncolytic Virus Market Facts & Figures by Country
- 5.7.1 South America Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oncolytic Virus Sales by Country (2021-2032)
- 5.7.3 South America Oncolytic Virus Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oncolytic Virus Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oncolytic Virus Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oncolytic Virus Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oncolytic Virus Sales by Type (2021-2032)
- 6.1.1 Global Oncolytic Virus Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Oncolytic Virus Sales Market Share by Type (2021-2032)
- 6.2 Global Oncolytic Virus Revenue by Type (2021-2032)
- 6.2.1 Global Oncolytic Virus Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oncolytic Virus Revenue Market Share by Type (2021-2032)
- 6.3 Global Oncolytic Virus Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oncolytic Virus Sales by Application (2021-2032)
- 7.1.1 Global Oncolytic Virus Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Oncolytic Virus Sales Market Share by Application (2021-2032)
- 7.2 Global Oncolytic Virus Revenue by Application (2021-2032)
- 7.2.1 Global Oncolytic Virus Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oncolytic Virus Revenue Market Share by Application (2021-2032)
- 7.3 Global Oncolytic Virus Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oncolytic Virus Value Chain Analysis
- 8.1.1 Oncolytic Virus Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oncolytic Virus Production Mode & Process
- 8.2 Oncolytic Virus Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oncolytic Virus Distributors
- 8.2.3 Oncolytic Virus Customers
9 Global Oncolytic Virus Analyzing Market Dynamics
- 9.1 Oncolytic Virus Industry Trends
- 9.2 Oncolytic Virus Industry Drivers
- 9.3 Oncolytic Virus Industry Opportunities and Challenges
- 9.4 Oncolytic Virus Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst